Eclipse Therapeutics Garners $2,775,000 New Funding

  • Feed Type
  • Date
    10/17/2011
  • Company Name
    Eclipse Therapeutics
  • Mailing Address
    Undisclosed San Diego , CA 92102
  • Company Description
    Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence.
  • Website
    http://www.eclipsetherapeutics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,775,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.